IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis

How the World's First Dengue Vaccination Drive Ended in Disaster

Dengue pre-vaccination screening test evaluation for the use of

Immunogenicity and safety of booster CYD-TDV dengue vaccine after

Is new dengue vaccine efficacy data a relief or cause for concern

Efficacy profile of the CYD-TDV dengue vaccine revealed by

Current Status of Vaccines against Dengue Virus

Dengue – the Region of the Americas

Pre-vaccination screening strategies for the use of the CYD-TDV

Four-year safety follow-up of the tetravalent dengue vaccine

Dengue Vaccine: Recommendations of the Advisory Committee on

By Ahmed Khaled Vaccine team Pfizer KSA - ppt download

IDSA on X: New in CID: A #dengue vaccine candidate was

Is new dengue vaccine efficacy data a relief or cause for concern

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of

Cost-effectiveness of dengue vaccination in Puerto Rico